352 results on '"Belvisi, Laura"'
Search Results
2. Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN
3. Synthesis of Noncoded Amino Acids Bearing a Salicylaldehyde Tag for the Design of Reversible‐Covalent Peptides.
4. Development of a highly selective glycomimetic ligand for L-SIGN: a new tool against SARS-CoV-2 and Ebola viruses
5. A Tight Contact: the Expanding Application of Salicylaldehydes in Lysine‐targeting Covalent Drugs
6. A Tight Contact: The Expanding Application of Salicylaldehydes in Lysine‐Targeting Covalent Drugs.
7. Glycomimetic antagonists of BC2L-C lectin: insights from molecular dynamics simulations
8. Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems
9. RGD Cyclopeptide Equipped with a Lysine‐Engaging Salicylaldehyde Showing Enhanced Integrin Affinity and Cell Detachment Potency
10. Identification of New L-Fucosyl and L-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia
11. A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands
12. Targeting a Multidrug-Resistant Pathogen: First Generation Antagonists of Burkholderia cenocepacia’s BC2L-C Lectin
13. Advanced Pyrrolidine‐Carbamate Self‐Immolative Spacer with Tertiary Amine Handle Induces Superfast Cyclative Drug Release
14. Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics
15. Electrostatic potential of a new angiotensin II receptor antagonist from X-ray diffraction and ab initio calculations
16. Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization
17. Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis
18. Editorial: Peptides Targeting Protein-Protein Interactions: Methods and Applications
19. Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy
20. Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia**
21. Functionalized 2‐Hydroxybenzaldehyde‐PEG Modules as Portable Tags for the Engagement of Protein Lysine ϵ‐Amino Groups
22. Synthesis and conformational studies of peptidomimetics containing a new bifunctional diketopiperazine scaffold acting as a [beta]-hairpin inducer
23. First round of a focused library of cholera toxin inhibitors
24. Synthesis and conformational analysis of an α-d-mannopyranosyl-(1→2)-α-d-mannopyranosyl-(1→6)-α-d-mannopyranose mimic
25. A trifunctional self-immolative spacer enables drug release with two non-sequential enzymatic cleavages
26. Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds
27. Simulation of carbohydrate-protein interactions: Computer-aided design of a second generation GM1 mimic
28. Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids
29. Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia Cenocepacia
30. Fast Cyclization of a Proline‐Derived Self‐Immolative Spacer Improves the Efficacy of Carbamate Prodrugs
31. Frontispiece: Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates
32. Multivalency Increases the Binding Strength of RGD Peptidomimetic‐Paclitaxel Conjugates to Integrin αVβ3
33. Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors
34. A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists
35. A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists
36. Synthesis of substituted conformationally constrained 6,5- and 7,5-fused bicyclic lactams as dipeptide mimics
37. Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates
38. Bromine‐Promoted Glycosidation of Conformationally Superarmed Thioglycosides
39. Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies
40. The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin α v β 3
41. Synthesis and Biological Evaluation of RGD and isoDGR–Monomethyl Auristatin Conjugates Targeting Integrin αVβ3
42. A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells
43. β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate
44. Structure-activity relationships of non-peptide Angiotensin II antagonists
45. Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin‐Targeted Conjugate
46. Practical stereoselective synthesis of conformationally constrained unnatural proline-based amino acids and peptidomimetics
47. Functionalized azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition
48. Frontispiece: Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3
49. Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies
50. Targeting Integrin αV β3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.